A carregar...

Interpretive Breakpoints for Fluconazole and Candida Revisited: a Blueprint for the Future of Antifungal Susceptibility Testing

Developing interpretive breakpoints for any given organism-drug combination requires integration of the MIC distribution, pharmacokinetic and pharmacodynamic parameters, and the relationship between in vitro activity and outcome from both in vivo and clinical studies. Previously, the Subcommittee fo...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Pfaller, M. A., Diekema, D. J., Sheehan, D. J.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2006
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1471993/
https://ncbi.nlm.nih.gov/pubmed/16614256
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/CMR.19.2.435-447.2006
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!